Back to results
US 11,535,621 B2Granted
Heterobicyclic amides as inhibitors of CD38
AssigneeRibon Therapeutics, Inc.
InventorsLaurie B. Schenkel, Melissa Marie Vasbinder, Kevin Wayne Kuntz, Nicholas Robert Perl, Jennifer Downing
Life of this patent
Estimating the term…
Abstract
The present invention relates to heterobicyclic amides and related compounds which are inhibitors of CD38 and are useful in the treatment of cancer.
Claims4
A compound which is N-((1r,4r)-4-(2-hydroxypropan-2-yl)cyclohexyl)-5-(1H-imidazol-1-yl)-1H-pyrazolo[4,3-d]pyrimidine-7-carboxamide, or a pharmaceutically acceptable salt thereof.
A compound which is N-((1r,4r)-4-(2-hydroxypropan-2-yl)cyclohexyl)-5-(1H-imidazol-1-yl)-1H-pyrazolo[4,3-d]pyrimidine-7-carboxamide.
Dependencies are inferred from the claim text.